Market Report, "Diabetic Nephropathy ...

Market Report, "Diabetic Nephropathy - Pipeline Review, H1 2012", published

There are 1 comment on the PR-inside.com story from Mar 30, 2012, titled Market Report, "Diabetic Nephropathy - Pipeline Review, H1 2012", published. In it, PR-inside.com reports that:

This report provides information on the therapeutic development for Diabetic Nephropathy, complete with latest updates, and special features on late-stage and discontinued projects.

Join the discussion below, or Read more at PR-inside.com.

Joan

Toronto, Canada

#1 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

ChemoCentryx Discussions

Title Updated Last By Comments
News IPO Preview: ChemoCentryx (May '12) May '12 Robson 1
News GSK licenses experimental arthritis treatment f... (May '12) May '12 Robson 1
News GSK Licenses RA Drug from ChemoCentryx (May '12) May '12 Robson 1
News GSK Exercises Option to License ChemoCentryx's ... (May '12) May '12 Robson 1
News GlaxoSmithKline Exercises Option to License Che... (May '12) May '12 Joan 1
News GSK obtains exclusive license to ChemoCentryx's... (May '12) May '12 Joan 1
News Drug developer ChemoCentryx has priced its IPO ... (May '12) May '12 Joan 1
More from around the web